Search
Search Results
##search.searchResults.foundPlural##
-
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4064PDF: 1562HTML: 9194Untitled: 287Untitled: 194Untitled: 180Untitled: 172Untitled: 196Untitled: 352 -
Anemia in the elderly: not always what it seems.
3349PDF: 1098HTML: 1788Figure 1: 192Figure 1 revised: 191 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4373PDF: 1222HTML: 2328Figure 1: 176 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3114PDF: 890HTML: 7179Kost Fig1: 200Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 203Kost Fig5: 202Kost fig 6: 188 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2685PDF: 763HTML: 2320 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1498PDF: 922Suppl. Files: 462HTML: 248 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3632PDF: 1100HTML: 881 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2935PDF: 1253HTML: 2722Figure 1: 185 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
439PDF: 430Suppl. Files: 60HTML: 32 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2257PDF: 992HTML: 1907 -
Pathologic splenic rupture in a patient with follicular lymphoma
1457PDF: 566HTML: 1197rupture: 188 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
239PDF: 272Suppl. Files: 49HTML: 54 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2240PDF: 1220HTML: 3884 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1812PDF: 952HTML: 1117Untitled: 172Untitled: 191Untitled: 172Untitled: 173 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3287PDF: 1040HTML: 2134 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4895PDF: 2896HTML: 2320 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2076PDF: 829HTML: 1055 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3690PDF: 1693HTML: 2685 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
2058PDF: 848HTML: 233 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3401PDF: 1998HTML: 7484 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1550PDF: 1099HTML: 226 -
Acquired Hemophilia A successfully treated with rituximab
2108PDF: 1164HTML: 1460Figure 1: 201 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1295PDF: 1038HTML: 235







